Matrix metalloproteinases: Old dogs with new tricks

Genome Biology

Volumn 4, Issue 6, 2003, Pages

  Somerville, Robert P T ^a   Oblander, Samantha A ^a   Apte, Suneel S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; COLLAGENASE 3; ELASTASE; GELATINASE; GENE PRODUCT; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; NEUTROPHIL COLLAGENASE; SCLEROPROTEIN; STROMELYSIN; STROMELYSIN 2;

CELL FUNCTION; CELL MIGRATION; CHROMOSOME 11Q; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SPECIFICITY; EXTRACELLULAR MATRIX; GENE CLUSTER; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC VARIABILITY; HOMEOSTASIS; HUMAN; MEDICAL GENETICS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; TRANSGENIC MOUSE; ANIMAL; CLASSIFICATION; GENETICS; MOLECULAR EVOLUTION; PHYSIOLOGY;

CANIS FAMILIARIS; MUS MUSCULUS;

ANIMALS; EVOLUTION, MOLECULAR; HUMANS; MATRIX METALLOPROTEINASES;

EID: 0037900632     PISSN: 14656906     EISSN: None     Source Type: Journal    
DOI: 10.1186/gb-2003-4-6-216     Document Type: Review

References (84)

1. Gross J, Lapiere CM: Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci USA 1962, 48:1014-1022.
2. Brinckerhoff CE, Matrisian LM: Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 2002, 3:207-214.
3. Coussens LM, Fingleton B, Matrisian LM: Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002, 295:2387-2392.
4. Vihinen P, Kahari VM: Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 2002, 99:157-166.
5. Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2:161-174.
6. Itoh Y, Nagase H: Matrix metalloproteinases in cancer. Essays Biochem 2002, 38:21-36
7. Pendas AM, Balbin M, Llano E, Jimenez MG, Lopez-Otin C: Structural analysis and promoter characterization of the human collagenase-3 gene (MMP 13). Genomics 1997, 40:222-233.
8. Shapiro SD: Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 1998, 10:602-608.
9. Balbin M, Fueyo A, Knauper V, Lopez JM, Alvarez J, Sanchez LM, Quesada V, Bordallo J, Murphy G, Lopez-Otin C: Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-I) expressed at sites of embryo implantation. J Biol Chem 2001, 276:10253-10262.
10. Wada K, Sato H, Kinoh H, Kajita M, Yamamoto H, Seiki M: Cloning of three Caenorhabditis elegans genes potentially encoding novel matrix metalloproteinases. Gene 1998, 211:57-62.
11. Llano E, Pendas AM, Aza-Blanc P, Kornberg TB, Lopez-Otin C: Dml-MMP, a matrix metalloproteinase from Drosophila with a potential role in extracellular matrix remodeling during neural development. J Biol Chem 2000, 275:35978-35985.
12. Lepage T, Gache C: Early expression of a collagenase-like hatching enzyme gene in the sea urchin embryo. EMBO J 1990, 9:3003-3012.
13. Leontovich AA, Zhang J, Shimokawa K, Nagase H, Sarras MP Jr: A novel hydra matrix metalloproteinase (HMMP) functions in extracellular matrix degradation, morphogenesis and the maintenance of differentiated cells in the foot process. Development 2000, 127:907-920.
14. Kinoshita T, Fukuzawa H, Shimada T, Saito T, Matsuda Y: Primary structure and expression of a gamete lytic enzyme in Chlamydomonas reinhardtii: similarity of functional domains to matrix metalloproteases. Proc Natl Acad Sci USA 1992, 89:4693-4687.
15. McGeehan G, Burkhart W, Anderegg R, Becherer JD, Gillikin JW, Graham JS: Sequencing and characterization of the soybean leaf metalloproteinase: structural and functional similarity to the matrix metalloproteinase family. Plant Physiol 1992, 99:1179-1193.
16. Maidment JM, Moore D, Murphy GP, Clark IM: Matrix metalloproteinse homologues from Arabidopsis thaliana. Expression and activity. J Biol Chem 1999, 275:34706-34712.
17. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994, 370:61-65.
18. Itoh Y, Kajita M, Kinoh H, Mori H, Okada A, Seiki M: Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase. J Biol Chem 1999, 274:34260-34266.
19. Pei D: CA-MMP: a matrix metalloproteinase with a novel cysteine array, but without the classic cysteine switch. FEBS Lett 1999, 457:262-270.
20. Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA: Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 1996, 85:683-693.
21. Guo H, Li R, Zucker S, Toole BP: EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface. Cancer Res 2000, 60:888-891.
22. Yu WH, Woessner JF Jr, McNeish JD, Stamenkovic I: CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 2002, 16:307-323.
23. Li Q, Park PW, Wilson CL, Parks WC: Matrilysin shedding of syndecan-I regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 2002, 111:635-646.
24. Bode W, Grams F, Reinemer P, Gomis-Ruth FX, Baumann U, McKay DB, Stocker W: The metzincin-superfamily of zinc-peptidases. Adv Exp Med Biol 1996, 389:1-11.
25. Stocker W, Bode W: Structural features of a superfamily of zinc-endopeptidases: the metzincins. Curr Opin Struct Biol 1995, 5:383-390.
26. Steffensen B, Wallon UM, Overall CM: Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen. J Biol Chem 1995, 270:11555-11566.
27. Shipley JM, Doyle GA, Fliszar CJ, Ye QZ, Johnson LL, Shapiro SD, Welgus HG, Senior RM: The structural basis for the elastolytic activity of the 92-kDa and 72- kDa gelatinases. Role of the fibronectin type II-like repeats. J Biol Chem 1996, 271:4335-4341.
28. Murphy G, Nguyen Q, Cockett MI, Atkinson SJ, Allan JA, Knight CG, Willenbrock F, Docherty AJ: Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. J Biol Chem 1994, 269:6632-6636.
29. Park HI, Ni J, Gerkema FE, Liu D, Belozerov VE, Sang QX Identification and characterization of human endometase (matrix metalloproteinase-26) from endometrial tumor. J Biol Chem 2000, 275:20540-20544.
30. Velasco G, Pendas AM, Fueyo A, Knauper V, Murphy G, Lopez-Otin C: Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members. J Biol Chem 1999, 274:4570-4576.
31. Morgunova E, Tuuttila A, Bergmann U, Isupov M, Lindqvist Y, Schneider G, Tryggvason K: Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. Science 1999, 284:1667-1670.
32. Nagase H, Meng Q, Malinovskii V, Huang W, Chung L, Bode W, Maskos K, Brew K: Engineering of selective TIMPs. Ann NY Acad Sci 1999,878:1-11.
33. Van Wart HE, Birkedal-Hansen H: The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 1990, 87:5578-5582.
34. Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M: Activation of a recombinant membrane type I-matrix metalloproteinase (MTI-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 1996, 393:101-104.
35. Wang X, Pei D: Shedding of membrane type matrix metalloproteinase 5 by a furin-type convertase: a potential mechanism for down-regulation. J Biol Chem 2001, 276:35953-35960.
36. Kang T, Nagase H, Pei D: Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the trans-Golgi network. Cancer Res 2002, 62:675-681.
37. Pei D, Weiss SJ: Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 1995, 375:244-247.
38. Baker AH, Edwards DR, Murphy G: Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 2002, 115:3719-3727.
39. Mott JD, Thomas CL, Rosenbach MT, Takahara K, Greenspan DS, Banda MJ: Post-translational proteolytic processing of procollagen C-terminal proteinase enhancer releases a metalloproteinase inhibitor. J Biol Chem 2000, 275:1384-1390.
40. Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, Nishimura S, Imamura Y, Kitayama H, Alexander DB, et al.: The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 2001, 107:789-800.
41. Takahashi C, Sheng Z, Horan TP, Kitayama H, Maki M, Hitomi K, Kitaura Y, Takai S, Sasahara. RM, Horimoto A, et al. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA 1998, 95:13221-13226.
42. Wang Z, Juttermann R, Soloway PD: TIMP-2 is required for efficient activation of proMMP-2 in vivo. J Biol Chem 2000, 275:26411-26415.
43. Apte SS, Fukai N, Beier DR, Olsen BR: The matrix metalloproteinase-14 (MMP-14) gene is structurally distinct from other MMP genes and is co-expressed with the TIMP-2 gene during mouse embryogenesis. J Biol Chem 1997, 272:25511-25517.
44. Knauper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM, Murphy G: Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MTI-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 1996, 271:17124-17131.
45. Lehti K, Valtanen H, Wickstrom S, Lohi J, Keski-Oja J: Regulation of membrane-type-I matrix metalloproteinase activity by its cytoplasmic domain. J Biol Chem 2000, 275:15006-15013.
46. Lehti K, Lohi J, Juntunen MM, Pei D, Keski-Oja J: Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type I matrix metalloproteinase. J Biol Chem 2002, 277:8440-8448.
47. Rozanov DV, Deryugina EI, Ratnikov BI, Monosov EZ, Marchenko GN, Quigley JP, Strongin AY: Mutation analysis of membrane type-I matrix metalloproteinase (MTI-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MTI-MMP expressed in breast carcinoma cells. J Biol Chem 2001, 276:25705-25714.
48. Nakahara H, Howard L, Thompson EW, Sato H, Seiki M, Yeh Y, Chen WT: Transmembrane/cytoplasmic domain-mediated membrane type I-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc Natl Acad Sci USA 1997, 94:7959-7964.
49. Annabi B, Lachambre M, Bousquet-Gagnon N, Page M, Gingras D, Beliveau R: Localization of membrane-type I matrix metalloproteinase in caveolae membrane domains. Biochem J 2001, 353:547-553.
50. Jiang A, Lehti K, Wang X, Weiss SJ, Keski-Oja J, Pei D: Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci USA 2001, 98:13693-13698.
51. Uekita T, Itoh Y, Yana I, Ohno H, Seiki M: Cytoplasmic tail-dependent internalization of membrane-type I matrix metalloproteinase is important for its invasion-promoting activity. J Cell Biol 2001, 155:1345-1356.
52. Yang Z, Strickland DK, Bornstein P: Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2. J Biol Chem 2001, 276:8403-8408.
53. Barmina OY, Walling HW, Fiacco GJ, Freije JM, Lopez-Otin C, Jeffrey JJ, Partridge NC: Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization. J Biol Chem 1999, 274:30087-30093.
54. Lovejoy B, Welch AR, Carr S, Luong C, Broka C, Hendricks RT, Campbell JA, Walker KA, Martin R, Van Wart H, Browner MF: Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors. Nat Struct Biol 1999, 6:217-221.
55. Olson MW, Toth M, Gervasi DC, Sado Y, Ninomiya Y, Fridman R: High affinity binding of latent matrix metalloproteinase-9 to the alpha2(IV) chain of collagen IV. J Biol Chem 1998, 273:10672-10681.
56. Suzuki M, Raab G, Moses MA, Fernandez CA, Klagsbrun M: Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J Biol Chem 1997, 272:31730-31737.
57. Imai K, Hiramatsu A, Fukushima D, Pierschbacher MD, Okada Y: Degradation-of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-betal release. Biochem J 1997, 322:809-814.
58. Whitelock JM, Murdoch AD, Iozzo RV, Underwood PA: The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J Biol Chem 1996, 271:10079-10086.
59. Manes S, Mira E, Barbacid MM, Cipres A, Fernandez-Resa P, Buesa JM, Merida, I, Aracil M, Marquez G, Martinez AC: Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3. J Biol Chem 1997, 272:25706-25712.
60. Fowlkes JL, Thrailkill KM, Serra DM, Suzuki K, Nagase H: Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases. Prog Growth Factor Res 1995, 6:255-263.
61. Fowlkes JL, Enghild JJ, Suzuki K, Nagase H: Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J Biol Chem 1994, 269:25742-25746.
62. Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM, Mareel M: Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2001, 114:111-118.
63. Steinhusen U, Weiske J, Badock V, Tauber R, Bommert K, Huber O: Cleavage and shedding of E-cadherin after induction of apoptosis. J Biol Chem 2001, 276:4972-4980.
64. Preece G, Murphy G, Ager A: Metalloproteinase-mediated regulation of L-selectin levels on leucocytes. J Biol Chem 1996, 271:11634-11640.
65. Asamoto M, Hokaiwado N, Cho YM, Takahashi S, Ikeda Y, Imaida K, Shirai T: Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter, control are strictly androgen dependent. Cancer Res 2001, 61:4693-4700.
66. Fujiwara K, Matsukawa A, Ohkawara S, Takagi K, Yoshinaga M: Functional distinction between CXC chemokines, interleukin-8 (IL-8), and growth related oncogene (GRO)alpha in neutrophil infiltration. Lab West 2002, 82:15-23.
67. McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, Clark-Lewis I, Overall CM: Matrix metalloproteinase activity inactivates the CXC chemokine stromall cell-derived factor-I. J Biol Chem 2001, 276:43503-43508.
68. Levi E, Fridman R, Miao HQ, Ma YS, Yayon A, Vlodavsky I: Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor I. Proc Natl Acad Sci USA 1996, 93:7069-7074.
69. Ganz, T: Defensins and host defense. Science 1999, 286:420-421.
70. Wilson CL, Ouellette AJ, Satchell DP, Ayabe T, Lopez-Boado YS, Stratman JL, Hultgren SJ, Matrisian LM, Parks WC: Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999, 286:113-117.
71. Gearing AJ, Thorpe SJ, Miller K, Mangan M, Varley PG, Dudgeon T, Ward G, Turner C, Thorpe R: Selective cleavage of human IgG by the matrix metalloproteinases, matrilysin and stromelysin. Immunol Lett 2002, 81:41-48.
72. Ruiz S, Henschen-Edman AH, Nagase H, Tenner AJ: Digestion of Clq collagen-like domain with MMPs-1,-2,-3, and -9 further defines the sequence involved in the stimulation of neutrophil superoxide production. J Leukoc Biol 1999, 66:416-422.
73. Feng X, Tonnesen MG, Peerschke EI, Ghebrehiwet B: Cooperation of Clq receptors and integrins in Clq-mediated endothelial cell adhesion and spreading. J Immunol 2002, 168:2441-2448.
74. Rozanov DV, Ghebrehiwet B, Postrova TI, Eichinger A, Deryugina EI, Strongin AY: The hemopexin-like C-terminal domain of membrane type I matrix metalloproteinase regulates proteolysis of a multifunctional protein, gClqR. J Biol Chem 2002, 277:9318-9325.
75. Martignetti JA, Aqeel AA, Sewairi WA, Boumah CE, Kambouris M, Mayouf SA, Sheth KV, Eid WA, Dowling O, Harris J, et al.: Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet 2001, 28:261-265.
76. Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I, et al.: MTI-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 1999, 99:81-92.
77. Zhou Z, Apte SS, Soininen R, Cao R, Baaklini GY, Rauser RW, Wang J, Cao Y, Tryggvason K: Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase 1. Proc Nod Acad Sci USA 2000, 97:4052-4057.
78. Gururajan R, Lahti JM, Grenet J, Easton J, Gruber I, Ambros PF, Kidd VJ: Duplication of a genomic region containing the Cdc2L1-2 and MMP21-22 genes on human chromosome Ip36.3 and their linkage to D1Z2. Genome Res 1998, 8:929-939.
79. Zhu Y, Spitz MR, Lei L, Mills GB, Wu X: A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 2001, 61:7825-7829.
80. Ghilardi G, Biondi ML, Mangoni J, Leviti S, DeMonti M, Guagnellini E, Scorza R: Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res 2001, 7:2344-2346.
81. Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ, Brinckerhoff CE: A single nucleoticle polymorphism in the matrix metalloproteinise-1 promoter creates an Ets binding site and augments transcription. Cancer Res 1998, 58:5321-5325.
82. Biondi ML, Turri O, Leviti S, Seminati R, Cecchini F, Bernini M, Ghilardi G, Guagnellini E: MMP1 and MMP3 polymorphisms in promoter regions and cancer. Clin Chem 2000, 46:2023-2024.
83. Parks WC, Shapiro SD: Matrix metalloproteinases in lung biology. Respir Res 2001, 2:10-19
84. Lopez-Otin C, Overall CM: Protease degradomics: a new challenge for proteomics. Not Rev Mol Cell Biol 2002, 3:509-519.